MLL1 Polyclonal Antibody

MLL1 Polyclonal Antibodyis available at Gentaur for Next week Delivery.

Description: Eukaryotic RNA polymerase II mediates the synthesis of mature and functional messenger RNA. This is a multistep process, called the transcription cycle, that includes five stages: preinitiation, promoter, clearance, elongation and termination. Elongation is thought to be a critical stage for the regulation of gene expression. ELL (11-19 lysine-rich leukemia protein, also designated MEN) functions as an RNA polymerase II elongation factor that increases the rate of transcription by suppressing transient pausing by RNA polymerase II. Also, ELL is thought to regulate cellular proliferation. ELL is abundantly expressed in peripheral blood leukocytes, skeletal muscle, placenta and testis, and has lower expression in spleen, thymus, heart, brain, lung, kidney, liver and ovary. The gene encoding human ELL, which maps to chromosome 19p13.1, is one of several genes which undergo translocation with the MLL gene on chromosome 11q23 in acute myeloid leukemia. MLL (myeloid/lymphoid leukemia, also designated ALL-1 and HRX) regulates embryonal and hematopoietic development.

Immunogen Sequence:Synthetic peptide of human MLL1

Target Alternative Name:MLL, MLL1, myeloid/lymphoid or mixed-lineage leukemia, HRX, TRX1, HTRX1, human trithorax 1, ALL-1, acute lymphocytic leukemia 1, CXXC7, HGNC:7132

Species Reactivities:Human, mouse

Tag Line:/

Formulation:In phosphate buffered saline (PBS), pH 7.2, containing 30% glycerol, 0.5% BSA, 5 mM EDTA and 0.03% proclin.

Purification: Affinity purified

Application:Western blot

Positive Control:/

Application And Usages:Western blotting (1:500 – 1:2000). However, the optimal concentrations should be determined individually. K562 nuclear extract can be used as a positive control. The antibody recognizes the MLL1 of human and mouse origins. Reactivity to other species has not been tested.

Handling:The antibody solution should be gently mixed before use.